Discovering genetically-supported drug targets for multisite chronic pain through multi-omics Mendelian randomization and single-cell RNA-sequencing
- 22 February 2025
- journal article
- Published by Elsevier in Neuroscience
- Vol. 572, 254-268
Abstract
No abstract availableKeywords
Funding Information
- Medical Science and Technology Foundation of Guangdong Province
This publication has 68 references indexed in Scilit:
- Leveraging molecular quantitative trait loci to comprehend complex diseases/traits from the omics perspectiveHuman Genetics, 2023
- Why 90% of clinical drug development fails and how to improve it?Acta Pharmaceutica Sinica B, 2022
- Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategiesAdvanced Drug Delivery Reviews, 2021
- Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivativesBioorganic Chemistry, 2020
- The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitationsThe Journal of Pathology, 2020
- Chronic pain: a review of its epidemiology and associated factors in population-based studiesBritish Journal of Anaesthesia, 2019
- Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for PainJAMA Network Open, 2019
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Spreading of chronic pain between body regions: Prospective cohort study among health care workersEuropean journal of pain, 2012